Search - tctmd.com

January 21, 2020

News Daily News

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

January 16, 2020

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

January 14, 2020

News Daily News

Year in Review: Digital Health and A-fib Ablation Top 2019 Heart Rhythm News

Todd Neale

December 19, 2019

News Daily News

Physicians as Patients: Better Health, Less CV Prevention Among Ontario Doctors Than General Public

November 26, 2019

News Daily News

Many ASCVD Patients Skimp on CV Meds Due to Costs: US Survey

Caitlin E. Cox

November 25, 2019

News Conference News AHA 2019

Apabetalone Falls Short in Diabetic ACS Patients With Low HDL: BETonMACE

November 21, 2019

News Conference News PCR London Valves 2019

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

November 20, 2019

News Daily News

Grief and CVD: Simple Regimen May Lower Risk

November 19, 2019

News Daily News

Apple Heart in Print: The Conversation on Data Privacy Continues

November 15, 2019

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

News Daily News

New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients

October 22, 2019

News Industry News

FIND FH® Makes Identifying and Diagnosing Individuals at Genetic Risk for Early Heart Attacks and Stroke Possible

October 21, 2019

News Daily News

Bulimia May Contribute to Premature CVD in Women

October 18, 2019

News Daily News

Statins Started in Kids With FH Provide Benefits in Adulthood

October 17, 2019

News

Chronic Stress in African-Americans Linked to Hypertension

Todd Neale

October 16, 2019

Presentation TCT 2019

Essentials of LVOTO Screening (And Device Specificity)

Presenter: Omar Khalique

September 28, 2019

News Conference News HFSA 2019

Virtual Doctor Visits Reduce Missed Appointments After HF Hospitalizations: ViV-HF

September 23, 2019

News Daily News

Bleeding on Low-Dose Antithrombotic Therapy a ‘Red Flag’ for New Cancers